US excess deaths
Currently above average in 50 States
https://www.cdc.gov/nchs/nvss/vsrr/covid19/excess_deaths.htm#dashboard
March 15 to November 7
Deaths nationwide, 18 % percent higher than normal
Deaths above normal, 326,000
Covid deaths, 251,715
US trends
https://covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases
Donald Trump, Jr., (42) tested positive on Friday, has entered quarantine
Canadian
Toronto prepares 28 day lockdown Monday
A normal Christmas is quite frankly right out of the question
Mexico
Over 1 million confirmed cases
Test confirmed deaths, 100,000
UK
https://coronavirus.data.gov.uk/details/cases
https://covid.joinzoe.com/data#interactive-map
ONS
https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/20november2020
8 November to 14 November 2020
England
Prevalence, 664,700 infections
One in 80 people
38,900 new cases per day
Rates increasing
London, East of England South East
Rates decreasing
North West, East Midlands
Highest positivity rates
Secondary school-aged, older teenagers, young adults
Wales
Positivity rates peaked end of October
One in 165
Northern Ireland
Rates decreasing over past four weeks
One in 135
Scotland
Rates levelled of
One in 155
WHO and remdesivir (20th November)
https://www.who.int/news-room/feature-stories/detail/who-recommends-against-the-use-of-remdesivir-in-covid-19-patients
https://www.dw.com/en/coronavirus-who-advises-against-remdesivir-for-hospitalized-covid-19-patients/a-55671134?maca=en-NL-Corona-Compact
https://bnf.nice.org.uk/drug/remdesivir.html
Conditional recommendation against the use of remdesivir in hospitalized patients
Regardless of disease severity
Currently no evidence that remdesivir improves survival and other outcomes
Guideline, developed by international guideline development group
28 clinical care experts, 4 patient-partners, one ethicist
Match scientif..
